Veronica Mollica

34PUBLICATIONS
78CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Aug 21, 2026
Pattern-based interpretation of SOX2 expression in ovarian teratomas: avoiding diagnostic pitfalls in the distinction between immature and mature neuroectodermal elements.

|May 13, 2026
Beyond One-Size-Fits-All Active Surveillance for Low-Risk Prostate Cancer: Risk-Adapted Follow-Up, De-Escalation Pathways, and Focal Therapy as Tailored Strategy.

|Mar 28, 2026
Oncofertility in Women with Renal Cell Carcinoma in the Immune Checkpoint Inhibitors Era: A Multidisciplinary Perspective.

Michele Miscia, Antonio Raffone, Veronica Mollica

|Jan 20, 2026
New insights into Nectin-4 expression in testicular choriocarcinoma and its potential treatment with Enfortumab Vedotin: analysis of a multi-institutional series and association with clinical-pathological features.

Costantino Ricci, Luisa Di Sciascio, Francesca Ambrosi

|Sep 19, 2025
Immunohistochemical expression of EZH2 in germ cell tumors of the testis: New insights into the genesis and epigenetic reprogramming of these fascinating tumors.

Sofia Melotti, Francesca Ambrosi, Tania Franceschini

|Sep 11, 2025
Immunohistochemical expression of Nectin-4 and potential implications for enfortumab vedotin therapy in germ cell tumors of the testis: a preliminary study.

Costantino Ricci, Francesca Ambrosi, Tania Franceschini

Pageof 6

Frequent Collaborators

26 joint publications

Francesco Massari

14 joint publications

Alessandro Rizzo

12 joint publications

Costantino Ricci

12 joint publications

Michelangelo Fiorentino